Welcome to Adeia's Fourth Quarter 2024 Earnings Conference Call. During today’s presentation, all parties will be in listen-only mode. Following the presentation the call will be open for questions. I ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Session: Poster Session B Abstract title:Combination immunotherapy with an albumin-binding interleukin-12 fusion protein that extends cytokine half-life, targets the tumor microenvironment, and ...

Cool Company Ltd faces challenges with low spot rates, rising drydock costs, and high spot exposure, potentially impacting ...